A Single Dose, Open, Randomized, 5-Way Crossover Study In Healthy Volunteers To Investigate The Pharmacokinetics Of PF-00258210 Administered Alone Or PF-00258210 Administered Together With PF-00610355 Either As A Free Or A Fixed Dose Combination.
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2010
At a glance
- Drugs PF 258210; PF 610355
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 28 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.